We only have this paper's title and publication details.
Read it at the sourceRandomized double-blind trial investigates AMG 108 in knee osteoarthritis, highlighting interleukin-1 receptor inhibition as a potential targeted therapy.
This study is registered with ClinicalTrials.gov with the identifier NCT00110942.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: